FR2347931A1 - Composition pharmaceutique contenant un inhibiteur de prostaglandine-synthetase et une prostaglandine luteolytique, et son application a la regulation du cycle menstruel - Google Patents

Composition pharmaceutique contenant un inhibiteur de prostaglandine-synthetase et une prostaglandine luteolytique, et son application a la regulation du cycle menstruel

Info

Publication number
FR2347931A1
FR2347931A1 FR7711110A FR7711110A FR2347931A1 FR 2347931 A1 FR2347931 A1 FR 2347931A1 FR 7711110 A FR7711110 A FR 7711110A FR 7711110 A FR7711110 A FR 7711110A FR 2347931 A1 FR2347931 A1 FR 2347931A1
Authority
FR
France
Prior art keywords
prostaglandin
regulation
pharmaceutical composition
application
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7711110A
Other languages
English (en)
French (fr)
Other versions
FR2347931B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2347931A1 publication Critical patent/FR2347931A1/fr
Application granted granted Critical
Publication of FR2347931B1 publication Critical patent/FR2347931B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7711110A 1976-04-14 1977-04-13 Composition pharmaceutique contenant un inhibiteur de prostaglandine-synthetase et une prostaglandine luteolytique, et son application a la regulation du cycle menstruel Granted FR2347931A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15249/76A GB1533928A (en) 1976-04-14 1976-04-14 Oestrus regulation

Publications (2)

Publication Number Publication Date
FR2347931A1 true FR2347931A1 (fr) 1977-11-10
FR2347931B1 FR2347931B1 (enExample) 1980-02-22

Family

ID=10055718

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7711110A Granted FR2347931A1 (fr) 1976-04-14 1977-04-13 Composition pharmaceutique contenant un inhibiteur de prostaglandine-synthetase et une prostaglandine luteolytique, et son application a la regulation du cycle menstruel

Country Status (5)

Country Link
US (1) US4089951A (enExample)
JP (1) JPS52125631A (enExample)
DE (1) DE2716379A1 (enExample)
FR (1) FR2347931A1 (enExample)
GB (1) GB1533928A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369128A (en) * 1993-06-21 1994-11-29 Iowa State University Research Foundation, Inc. Method of synchronizing farrowing in swine
WO1997045113A1 (en) * 1996-05-30 1997-12-04 Sepracor Inc. Nsaids for regulating the reproductive cycle of domesticated animals
EP1610803B8 (en) * 2003-03-04 2011-09-14 AspenBio Pharma, Inc. LH for use in maintaining one or more pregnancies by inducing accessory corpus luteum formation.
WO2007047811A2 (en) * 2005-10-19 2007-04-26 Scott Josephson Improved reproductive management
US8096940B2 (en) * 2005-10-19 2012-01-17 Iversync Ii Llc Reproductive management

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3781429A (en) * 1972-09-29 1973-12-25 American Cyanamid Co Method of inhibiting ulcerogenesis induced by non-steroidal anti-inflammatory agents
US3937801A (en) * 1973-07-10 1976-02-10 American Home Products Corporation Reducing the incidence of gastrointestinal side effects during the treatment of inflammatory conditions with antiinflammatory drugs
US3928588A (en) * 1974-02-22 1975-12-23 Upjohn Co Method of reducing the undesirable gastrointestinal effects of prostaglandin synthetase inhibitors

Also Published As

Publication number Publication date
DE2716379A1 (de) 1977-11-10
FR2347931B1 (enExample) 1980-02-22
GB1533928A (en) 1978-11-29
US4089951A (en) 1978-05-16
JPS52125631A (en) 1977-10-21

Similar Documents

Publication Publication Date Title
CA1273019C (en) ENKEPHALINASE INHIBITORS
FR2301497A1 (fr) Composition d'engrais
FR2370753A1 (fr) Derives du glucofurannose et leur application therapeutique
FR2285854A1 (fr) Derives du phenyl-2 benzofuranne et compositions cosmetiques les contenant
FR2281376A1 (fr) Synthese de l'hydroxymethylphosphonate de di-polyoxyethylene
BE835803A (fr) Composition de detergent liquide
BE870531A (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
IT1098308B (it) Procedimento di sintesi dell'acido ascorbico
PL201756A1 (pl) Katalityczny sposob uplynniania wegla
DK518476A (da) Fremgangsmade til nedsettelse af den for opnaelse af en vis biologisk virkning nodvendige mengde af en biologisk aktiv forbindelse
BE824246A (fr) Production catalytique d'halogenures organostanniques
BE810959A (fr) Synthese asymetrique de chrysanthemates d'alkyle
FR2315266A1 (fr) Nouvelle composition pharmaceutique a base d'une lactone de prostaglandine
FR2347931A1 (fr) Composition pharmaceutique contenant un inhibiteur de prostaglandine-synthetase et une prostaglandine luteolytique, et son application a la regulation du cycle menstruel
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
FR2277891A1 (fr) Methode pour deceler par radio-immunometrie la presence d'anticorps de la blennorragie
FR2291983A1 (fr) Purification de l'urokinase
BE836084A (fr) Masses d'uree fluides
RO66809A (ro) Diblu de spraituire
BE880328Q (fr) Nouvelle composition therapeutique contenant de la levure, du soufre mineral et organique et de la vitamine a
FR2320298A1 (fr) Preparation de composes d'oxerane a partir de melange contenant des hydroxyesters
BE888238A (fr) Compositions stabilisees contenant des derives n-aminosulfenyles du carbofuranne,
FR1248882A (fr) Procédé d'établissement d'un nouvel empaquetage réfrigérant
BE827009A (fr) Composition detergente liquide depourvue d'adjuvants
RO73936A (ro) Compozitie de explozivi aposi

Legal Events

Date Code Title Description
ST Notification of lapse